It was a week of welcome news and encouraging milestones in the COVID-19 response, especially in the U.S., where the federal government passed a $1.9 trillion COVID-19 relief package and President Biden announced a goal to...more
With significant headway in the vaccine distribution and certain states already lifting COVID-19 restrictions, U.S. leaders are beginning to contemplate when we might return to some semblance of normalcy. Two Million...more
As we approach the one-year mark of COVID-19’s widespread presence in the United States, vaccines are being distributed, manufacturing is increased to meet demand and news of new vaccines all looks promising. While the world...more
Wednesday marked the beginning of a new presidency and with it a new chapter in the U.S. COVID-19 response. The Biden administration immediately unveiled a number of executive orders designed to take control of the pandemic....more
With Inauguration Day rapidly approaching, President-elect Biden has announced an ambitious vaccination plan, and the federal government has signaled a change to its vaccine distribution process, among other COVID-19...more
In an otherwise troubling week, there are some positive developments in the COVID-19 response, including progress in the development of a new vaccine.
The Pandemic Is Far from Over: 4000 Lives Gone in One Day ...more
A milestone in the vaccine approval process and a bipartisan relief package proposal highlighted a busy week in the COVID-19 response.
COVID-19 Relief Package -
This week, a group of bipartisan senators put forth the...more
As countries in the Western Hemisphere prepare for the first shipments of vaccines, researchers continue to release new COVID-19 findings.
Vaccine News Galore!
U.K. Approves COVID-19 Vaccine, Ahead in the Western World:...more
Positive news is emerging on the vaccine front in the fight against COVID-19, as one vaccine candidate is reported to have prevented more than 90% of symptomatic infections in clinical trials, and another was granted a Fast...more
Why Do Clinical Trials?
Clinical trials are an important — and government-required — step on the way from an idea to a commercial medicinal product. All new pharmaceutical and biological products and most generic...more
The daily number of new positive COVID-19 cases in the U.S. has exceeded 100,000 twice in the past week, prompting some states to issue more restrictive safety measures and guidance. Amid these heightened concerns, the most...more
Amid spikes on in the U.S, and Europe, Congress continues to ponder a relief bill, the White House released a plan to cover COVID-19 vaccine costs, and new data showed that chronic exposure to low-quality air increased...more
As talks of a third wave of infections bubble up and political negotiations over another COVID-19 relief package continue to stall, the pressure is on for the health and life science fields to better understand and tamp down...more
As a second COVID-19 wave hits Europe, many countries are implementing lockdown restrictions to flatten the curve. The second wave coincides with a pause in two vaccine clinical trials and the emergence of some documented...more
There are an average of 45,000 new COVID-19 cases in the United States daily, an increase of 8% from the previous week. States that were already on an upward trajectory are getting worse and hospitalizations are on the rise,...more
As COVID-19 cases rise across the U.S. and the death toll tops a staggering 200,000, four public health officials expressed confidence in an eventual vaccine even as the public's confidence in the vaccine appears to be waning...more
A recent report from the Centers for Disease Control and Prevention (CDC) revealed that dining out carries heightened risk of COVID-19 transmission, but did not reveal a similar heightened risk related to travel. Studies...more
AstraZeneca’s Phase 3 vaccine clinical trials came to a halt this week as the pharmaceutical company works to identify the underlying cause of a case of transverse myelitis emerging in a volunteer. The pause coincided with...more
Rising unemployment rates, continued deliberations on another federal relief package, and schools implementing remote learning after on-campus spikes in case rates marked an eventful week in the COVID-19 pandemic response....more
Recently, public attention has been captured by the progress of medical treatments and vaccines against COVID-19, which are currently going through clinical trials (categorized into phases 1, 2 and 3)....more
On March 20, 2020, the Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) issued a new guidance document for industry and FDA staff, attempting to “help expand the availability and capability...more